These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 26295054)
21. Plasma angiogenesis and oxidative stress markers in patients with diabetic retinopathy. Gaonkar B; Prabhu K; Rao P; Kamat A; Rao Addoor K; Varma M Biomarkers; 2020 Jul; 25(5):397-401. PubMed ID: 32529845 [No Abstract] [Full Text] [Related]
22. Influence of serum lipids on clinically significant versus nonclinically significant macular edema: SN-DREAMS Report number 13. Raman R; Rani PK; Kulothungan V; Rachepalle SR; Kumaramanickavel G; Sharma T Ophthalmology; 2010 Apr; 117(4):766-72. PubMed ID: 20045565 [TBL] [Abstract][Full Text] [Related]
23. Enhanced depth imaging optical coherence tomography in type 2 diabetes. Querques G; Lattanzio R; Querques L; Del Turco C; Forte R; Pierro L; Souied EH; Bandello F Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6017-24. PubMed ID: 22879414 [TBL] [Abstract][Full Text] [Related]
24. Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy. Marques IP; Madeira MH; Messias AL; Santos T; Martinho AC; Figueira J; Cunha-Vaz J J Clin Med; 2020 May; 9(5):. PubMed ID: 32408522 [TBL] [Abstract][Full Text] [Related]
25. Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy. Sasongko MB; Wong TY; Jenkins AJ; Nguyen TT; Shaw JE; Wang JJ Diabet Med; 2015 May; 32(5):686-91. PubMed ID: 25407692 [TBL] [Abstract][Full Text] [Related]
26. Four-year incidence and progression of diabetic retinopathy and macular edema: the Los Angeles Latino Eye Study. Varma R; Choudhury F; Klein R; Chung J; Torres M; Azen SP; Am J Ophthalmol; 2010 May; 149(5):752-61.e1-3. PubMed ID: 20149342 [TBL] [Abstract][Full Text] [Related]
27. The correlation between optical coherence tomographic features and severity of retinopathy, macular thickness and visual acuity in diabetic macular edema. Alkuraya H; Kangave D; Abu El-Asrar AM Int Ophthalmol; 2005 Jun; 26(3):93-9. PubMed ID: 17063373 [TBL] [Abstract][Full Text] [Related]
28. A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Miljanovic B; Glynn RJ; Nathan DM; Manson JE; Schaumberg DA Diabetes; 2004 Nov; 53(11):2883-92. PubMed ID: 15504969 [TBL] [Abstract][Full Text] [Related]
29. Foveal cone function in nonproliferative diabetic retinopathy and macular edema. Weiner A; Christopoulos VA; Gussler CH; Adams DH; Kaufman SR; Kohn HD; Weidenthal DT Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1443-9. PubMed ID: 9191608 [TBL] [Abstract][Full Text] [Related]
30. Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema. Krepler K; Biowski R; Schrey S; Jandrasits K; Wedrich A Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):735-8. PubMed ID: 12271370 [TBL] [Abstract][Full Text] [Related]
31. Microaneurysm formation rate as a predictive marker for progression to clinically significant macular edema in nonproliferative diabetic retinopathy. Haritoglou C; Kernt M; Neubauer A; Gerss J; Oliveira CM; Kampik A; Ulbig M Retina; 2014 Jan; 34(1):157-64. PubMed ID: 23792485 [TBL] [Abstract][Full Text] [Related]
32. TGF-β Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy. Bonfiglio V; Platania CBM; Lazzara F; Conti F; Pizzo C; Reibaldi M; Russo A; Fallico M; Ortisi E; Pignatelli F; Longo A; Avitabile T; Drago F; Bucolo C Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33334029 [TBL] [Abstract][Full Text] [Related]
33. A decrease in VEGF and inflammatory markers is associated with diabetic proliferative retinopathy. Blum A; Socea D; Ben-Shushan RS; Keinan-Boker L; Naftali M; Segol G; Tamir S Eur Cytokine Netw; 2012; 23(4):158-62. PubMed ID: 23328414 [TBL] [Abstract][Full Text] [Related]
34. The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes. Fenwick EK; Xie J; Ratcliffe J; Pesudovs K; Finger RP; Wong TY; Lamoureux EL Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):677-84. PubMed ID: 22205611 [TBL] [Abstract][Full Text] [Related]
35. Combined poor diabetes control indicators are associated with higher risks of diabetic retinopathy and macular edema than poor glycemic control alone. Fenwick EK; Xie J; Man REK; Sabanayagam C; Lim L; Rees G; Wong TY; Lamoureux EL PLoS One; 2017; 12(6):e0180252. PubMed ID: 28662119 [TBL] [Abstract][Full Text] [Related]
36. Risk factors for progression of subclinical diabetic macular oedema. Bhavsar KV; Subramanian ML Br J Ophthalmol; 2011 May; 95(5):671-4. PubMed ID: 21071757 [TBL] [Abstract][Full Text] [Related]
37. Assessment of Circulating Biomarkers in Relation to Various Stages of Diabetic Retinopathy in Type 2 Diabetic Patients-A Cross Sectional Study. Mathala N; Akula A; Hegde S; Bitra R; Sachedev V Curr Diabetes Rev; 2020; 16(4):402-409. PubMed ID: 31441730 [TBL] [Abstract][Full Text] [Related]
38. Microaneurysm turnover is a biomarker for diabetic retinopathy progression to clinically significant macular edema: findings for type 2 diabetics with nonproliferative retinopathy. Nunes S; Pires I; Rosa A; Duarte L; Bernardes R; Cunha-Vaz J Ophthalmologica; 2009; 223(5):292-7. PubMed ID: 19372723 [TBL] [Abstract][Full Text] [Related]
39. Increased Serum Chemerin Levels in Diabetic Retinopathy of Type 2 Diabetic Patients. Du J; Li R; Xu L; Ma R; Liu J; Cheng J; Zhang Z; Sun H Curr Eye Res; 2016; 41(1):114-20. PubMed ID: 25848840 [TBL] [Abstract][Full Text] [Related]
40. Subfoveal choroidal thickness in patients with diabetic retinopathy and diabetic macular oedema. Rewbury R; Want A; Varughese R; Chong V Eye (Lond); 2016 Dec; 30(12):1568-1572. PubMed ID: 27518549 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]